Advertisement
Screener

Indaptus Therapeutics, Inc. (INDP) Other

Indaptus Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-05-15: Form 10-Q; Item Stock registered under Section 12(b); As filed Common stock, par value $0.01 per share · INDP · NASDAQ.
  • 2026-03-17: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, par value $0.01 · INDP · NASDAQ.
  • 2025-11-12: Form 10-Q; Item Stock registered under Section 12(b); As filed Common stock, par value $0.01 per share · INDP · NASDAQ.
  • 2025-08-13: Form 10-Q; Item Stock registered under Section 12(b); As filed Common stock, par value $0.01 per share · INDP · NASDAQ.
FiledFormItemAs filed
2026-05-1510-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2026-03-1710-KStock registered under Section 12(b)Common stock, par value $0.01 · INDP · NASDAQ
2025-11-1210-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2025-08-1310-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2025-05-1410-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2025-03-1310-KStock registered under Section 12(b)Common stock, par value $0.01 · INDP · NASDAQ
2024-11-1210-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2024-08-1210-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2024-05-0810-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2024-03-1310-KStock registered under Section 12(b)Common stock, par value $0.01 · INDP · NASDAQ
2023-11-0610-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2023-08-1410-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2023-05-1110-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2023-03-1710-KStock registered under Section 12(b)Common stock, par value $0.01 · INDP · NASDAQ
2022-11-1010-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2022-08-0810-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2022-03-2110-KStock registered under Section 12(b)Common stock, par value $0.01 · INDP · NASDAQ
2021-11-1510-QStock registered under Section 12(b)Common stock, par value $0.01 per share · INDP · NASDAQ
2021-08-1610-QCurrent in its reportingNo
2021-06-2810-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
ARVINAS, INC. (ARVN)United States$0.510B58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82